DIALYSIS · CCN 102829

DaVita Apopka Dialysis

APOPKA, FL 32703

DialysisProfitDaVita
$5.5M
TOTAL REVENUE
34.9%
OPERATING MARGIN
3 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$5.5M
Total costs
$3.6M
Operating income (rev − costs)
$1.9M
Operating margin
34.9%
Total charges
$4.9M
Total treatments
12,173
Dialysis stations
24

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.5599—
Fistula Rate
DFC_FISTULA_RATE
57.1102—
Five Star Rating
DFC_FIVE_STAR
3——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
047—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
3——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
178.589—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.32——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
9102—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
21.6403—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
7.774—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
28.2129—
Standardized ED Visits Ratio
DFC_SEDR
0.6131—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
6.623—